lactic acid has been researched along with Neurocysticercosis in 2 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Neurocysticercosis: Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The debut study was aimed to develop Lactic acid (LA)-conjugated solid lipid nanoparticles (SLN-LA) bearing albendazole (ALB) and prednisolone (PRD) for effective management of neurocysticercosis (NCC)." | 7.81 | Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis. ( Devi, R; Hurkat, P; Jain, A; Jain, SK, 2015) |
| "Nitazoxanide (NTZ) is an antifolate containing the pyrrolopyrimidine-based nucleus that exerts its antiprotozoal activity due to interference with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme which is essential to anaerobic energy metabolism." | 5.51 | Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci. ( Alves, DSMM; Costa, TL; Isac, E; Lima, NF; Lino Junior, RS; Picanço, GA; Silva, LD; Vinaud, MC, 2019) |
| "The debut study was aimed to develop Lactic acid (LA)-conjugated solid lipid nanoparticles (SLN-LA) bearing albendazole (ALB) and prednisolone (PRD) for effective management of neurocysticercosis (NCC)." | 3.81 | Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis. ( Devi, R; Hurkat, P; Jain, A; Jain, SK, 2015) |
| "Nitazoxanide (NTZ) is an antifolate containing the pyrrolopyrimidine-based nucleus that exerts its antiprotozoal activity due to interference with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme which is essential to anaerobic energy metabolism." | 1.51 | Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci. ( Alves, DSMM; Costa, TL; Isac, E; Lima, NF; Lino Junior, RS; Picanço, GA; Silva, LD; Vinaud, MC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lima, NF | 1 |
| Picanço, GA | 1 |
| Alves, DSMM | 1 |
| Silva, LD | 1 |
| Isac, E | 1 |
| Costa, TL | 1 |
| Lino Junior, RS | 1 |
| Vinaud, MC | 1 |
| Devi, R | 1 |
| Jain, A | 1 |
| Hurkat, P | 1 |
| Jain, SK | 1 |
2 other studies available for lactic acid and Neurocysticercosis
| Article | Year |
|---|---|
Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci.
Topics: Administration, Oral; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Cysticercus; Ene | 2019 |
Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis.
Topics: Animals; Drug Carriers; Drug Delivery Systems; Humans; Kinetics; Lactic Acid; Lipids; Nanoparticles; | 2015 |